Fulton Breakefield Broenniman LLC Has $699,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fulton Breakefield Broenniman LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,339 shares of the medical equipment provider’s stock after selling 23 shares during the period. Fulton Breakefield Broenniman LLC’s holdings in Intuitive Surgical were worth $699,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. BSW Wealth Partners increased its position in shares of Intuitive Surgical by 6.1% during the fourth quarter. BSW Wealth Partners now owns 1,556 shares of the medical equipment provider’s stock valued at $812,000 after purchasing an additional 90 shares during the period. Bensler LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $1,316,000. Perigon Wealth Management LLC grew its position in Intuitive Surgical by 6.4% in the fourth quarter. Perigon Wealth Management LLC now owns 5,804 shares of the medical equipment provider’s stock valued at $3,029,000 after acquiring an additional 350 shares during the period. Buffington Mohr McNeal grew its position in Intuitive Surgical by 6.5% in the fourth quarter. Buffington Mohr McNeal now owns 507 shares of the medical equipment provider’s stock valued at $265,000 after acquiring an additional 31 shares during the period. Finally, Nilsine Partners LLC grew its position in Intuitive Surgical by 9.5% in the fourth quarter. Nilsine Partners LLC now owns 6,889 shares of the medical equipment provider’s stock valued at $3,596,000 after acquiring an additional 595 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Up 0.1 %

Shares of ISRG opened at $574.14 on Wednesday. The company has a market capitalization of $204.50 billion, a PE ratio of 92.31, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock’s 50-day moving average price is $548.00 and its two-hundred day moving average price is $506.12.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent analyst reports. Truist Financial boosted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Finally, Wells Fargo & Company upped their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,749 shares of company stock valued at $15,303,875. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.